Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Raloxifene/Cholecalciferol FDC vs Co-administration
NCT03010267Phase 1Completed
- Sponsor
- Alvogen
- Start
- Jan 2017
- Primary completion
- Mar 2017
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Phase 1, randomised, open-label trial of raloxifene and vitamin d in osteoporosis (2 arms), sponsored by Alvogen. Primary endpoints: Area under the plasma concentration versus time curve and Peak Plasma Concentration. Started Jan 2017; status: completed.
02
Drugs
raloxifenevitamin d
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT03010267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03010267.